Rona Silkiss, MD, a board-certified ophthalmologist, has begun to offer oculofacial plastic surgery and consultation services at the North Bay Eye Associates ambulatory surgery center in Santa Rosa, Calif.
Ophthalmology
La Peer Health Systems, an outpatient surgery center in Beverly Hill, Calif., has announced that it has been joined by Aaron Savar, a board-certified ophthalmologist.
RXi Pharmaceuticals, biotechnology company headquartered in Westborough, Mass., has announced it will present its work on the use of its sd-rxRNAs in retinoblastoma and proliferative vitreoretinopathy therapies at the Association for Research in Vision and Ophthalmology 2013 Annual Meeting.
IRIDEX, Mountain View, Calif.-based laser-based medical systems development company, has announced the recent sale of over $500,000 of its laser systems designed to treat eye conditions to the Brazilian, Russian, Chinese and Indian markets.
InSite Vision, Alameda, Calif.-based ophthalmological products company, has announced that it will be presenting five sponsored posters at the Association for Research in Vision and Ophthalmology 2013 Annual Meeting.
Palmetto Eye & Laser Center in Spartanburg, S.C., has acquired the Alcon WaveLight Refractive suite to offer its patients LASIK procedures, according to a Go Upstate report.
This spring, Phillips Eye & Surgery Center in Flemington, N.J., will hold an exhibit of artwork from Hunterdon Regional High School and Hunterdon Watercolor Society, according to an NJ.com report.
R-Tech Ueno, Japanese pharmaceutical company, has filed for and received FDA IND approval to begin Phase I and II clinical trials of its severe dry eye treatment, RU -101.
Pharm-Olam International, contract research organization for InSite Vision, has completed a Phase 3 clinical trial of BromSite, an anti-inflammatory designed to reduce swelling and pain after cataract surgery.
A three-year study led by Andrew Lotery, MD, ophthalmologist and professor at Southampton General Hospital in the U.K., has found that 65 percent of liver transplant patients developed age-related macular degeneration within five years of receiving the transplant, according to…
